510(k) Report

510(k) · Cleared

Cleared

Nova Max One Blood Glucose Monitor, Nova Max One Blood Glucose Test Strips

K112638510(k) TraditionalCleared Mar 9, 2012182-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nova Biomedical Corporation · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Mar 9, 2012 as substantially equivalent to K070255 (Nova Biomedical Corp., 2007) and 2 other predicates after a 182-day review. Its family tree reaches back 9 generations to 1995. 1 of the 34 devices in its family, counting itself, has a Class I recall. 3 later devices descend from it.

Decided
Mar 9, 2012
Review
182 days
Class
Class II
Product code
NBW
Recalls
None
Predicates
3

Its longest line of descent runs back 9 generations to K945887 (1995). 30 ancestors in all, the oldest K896951 (1990). 3 later devices descend from it, 2 citing it directly. 1 of the 34 devices in this family, counting this one, has a Class I recall.

  1. Root · 9 generations backK945887 Precision Q I D Blood Glucose Test StripsMedisense, Inc. · 1995
  2. 5 generations between
  3. 3 generations backK050500 Freestyle 600 Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2005
  4. 2 generations backK051839 Free-Style Freedom Blood Glucose Monitoring System, Model 11001Abbott Diabetes Care, Inc. · 2006 · Recalled
  5. 1 generation backK092638 Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01…Abbott Diabetes Care, Inc. · 2010 · Recalled (Class I)
  6. This deviceK112638 Nova Max One Blood Glucose Monitor, Nova Max One Blood Glucose Test…Nova Biomedical Corporation · 2012
  7. Descendant · cites it directly · 1 of its ownK122435 Nova One Blood Glucose MonitorNova Biomedical Corporation · 2012
  8. Descendant · 2 generations on · 0 of its ownK131013 Focus Blood Glucose Monitoring System, Focus Pro Blood Glucose…Nova Biomedical Corporation · 2013
  9. Descendant · cites it directly · 0 of its ownK122688 Nova Max Mini Blood Glucose and B-Ketone MonitorNova Biomedical Corporation · 2013
Show all 9 generations
  1. Root · 9 generations backK945887 Precision Q I D Blood Glucose Test StripsMedisense, Inc. · 1995
  2. 8 generations backK962295 Precision Qid Blood Glucose Test StripMedisense, Inc. · 1996
  3. 7 generations backK963676 Precision G Blood Glucose Testing SystemMedisense, Inc. · 1997
  4. 6 generations backK971812 Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose…Medisense, Inc. · 1997
  5. 5 generations backK982303 Precision PCX Point of Care Management System , QC Manager Data…Medisense, Inc. · 1998
  6. 4 generations backK022941 Medisense Precision PCX Point of Care Management System for Blood…Abbott Laboratories · 2002
  7. 3 generations backK050500 Freestyle 600 Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2005
  8. 2 generations backK051839 Free-Style Freedom Blood Glucose Monitoring System, Model 11001Abbott Diabetes Care, Inc. · 2006 · Recalled
  9. 1 generation backK092638 Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01…Abbott Diabetes Care, Inc. · 2010 · Recalled (Class I)
  10. This deviceK112638 Nova Max One Blood Glucose Monitor, Nova Max One Blood Glucose Test…Nova Biomedical Corporation · 2012

Class I recalls in this family

Most influential descendants

Showing 3 of 3 · See all
  • K122435Nova One Blood Glucose MonitorNova Biomedical Corporation · 2012 · cites it directly1descendant
  • K131013Focus Blood Glucose Monitoring System, Focus Pro Blood Glucose Monitoring SystemNova Biomedical Corporation · 2013 · 2 generations on0descendants
  • K122688Nova Max Mini Blood Glucose and B-Ketone MonitorNova Biomedical Corporation · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K945887Precision Q I D Blood Glucose Test StripsMedisense, Inc.1995—
−8K962295Precision Qid Blood Glucose Test StripMedisense, Inc.1996—
−7K963676Precision G Blood Glucose Testing SystemMedisense, Inc.1997—
−6K971812Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose Test StripMedisense, Inc.1997—
−5K982303Precision PCX Point of Care Management System , QC Manager Data Manager…Medisense, Inc.1998—
−4K022941Medisense Precision PCX Point of Care Management System for Blood Glucose…Abbott Laboratories2002—
−3K050500Freestyle 600 Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc.2005—
−2K051839Free-Style Freedom Blood Glucose Monitoring System, Model 11001Abbott Diabetes Care, Inc.20062
−1K092638Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21…Abbott Diabetes Care, Inc.2010Class I
0 (this device)K112638Nova Max One Blood Glucose Monitor, Nova Max One Blood Glucose Test StripsNova Biomedical Corporation2012—
+1K122435Nova One Blood Glucose MonitorNova Biomedical Corporation2012—
+2K131013Focus Blood Glucose Monitoring System, Focus Pro Blood Glucose Monitoring SystemNova Biomedical Corporation2013—
+1K122688Nova Max Mini Blood Glucose and B-Ketone MonitorNova Biomedical Corporation2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199220
199310
199530
199620
199720
199830
200030
200110
200210
200310
200710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201320
FIG. 1 — Lineage of K112638, 1995–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070255Nova Max Blood Glucose Monitor System, 90001,90002
Summary page 2
…are manufactured by Nova Biomedical and Identical to those cleared for market with the predicate Nova Max Blood Glucose Monitor System (K070255). Intended Use: The Nova Max One Blood Glucose Monitor is intended to be used for the quantitative measuremen…
Nova Biomedical Corp.2007—
*K051839Free-Style Freedom Blood Glucose Monitoring System, Model 11001
Summary page 1
…t, Blood Glucose, Over the Counter Name: Product Codes: NB3W, LFR, JJX Predicate Device: K(070255 - Nova Max Blood Glucose Monitor System K(051839 - FreeStyle Freedom Blood Glucose Monitoring System K(092638 - FreeStyle Blood Glucose Test Shrips Device…
Abbott Diabetes Care, Inc.20062
*K092638Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21, 12101-22…
Summary page 1
…edicate Device: K(070255 - Nova Max Blood Glucose Monitor System K(051839 - FreeStyle Freedom Blood Glucose Monitoring System K(092638 - FreeStyle Blood Glucose Test Shrips Device Nova Max One Blood Glucose Monitor Description: The monitor is…
Abbott Diabetes Care, Inc.2010Class I

Also cleared against K070255: 3 other devices →

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K122435Nova One Blood Glucose MonitorNova Biomedical Corporation20121
K122688Nova Max Mini Blood Glucose and B-Ketone MonitorNova Biomedical Corporation20130

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K092638Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21, 12101-22, 12101-23Abbott Diabetes Care, Inc. · 2010 · Direct predicate · ◆ on the line of descent in FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 17 years and passes through 4 companies; a new generation was cleared every 1.3 years on median.
  • 7 of the 30 ancestors have a recall of any class; 1 has a Class I recall.
  • Of its descendants, K122435 (Nova Biomedical Corporation, 2012) has gone furthest, with 1 descendant of its own.
  • 3 other devices also cite its predicate K070255.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The Nova Max One Blood Glucose Monitor is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood. Itis intended for single-patient home use and should not be used for testing multiple patients. It is intended for self testing outside the body by people with diabetes mellitus as an aid to monitor the effectiveness of diabetes contmol. The Nova Max One Blood Glucose Monitor is specifically indicated for the…

Read the full statement (297 words)

The Nova Max One Blood Glucose Monitor is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood. Itis intended for single-patient home use and should not be used for testing multiple patients. It is intended for self testing outside the body by people with diabetes mellitus as an aid to monitor the effectiveness of diabetes contmol. The Nova Max One Blood Glucose Monitor is specifically indicated for the quantitative measurement of glucose in fresh whore blood capillary samples obtained from the fingertip or alternative site testing (AST) on the forearm. AST on the forearm can be used only during steady-state blood glucose conditions. It is not intended for the diagnosis of or screening for diabetes. and it is not intended for use on newborns.

Nova Max One Glucose Test Strips are intended for use only with the Nova Max One Blood Glucose Monitor for quantitative tests. The Glucose Monitor isintended to quantitatively measure glucose (sugar) in fresh capillary whole blood obtained from the finger tip or alternative site testing (AST) on the forearm. AST can be used only during steady-state blood glucose conditions. The Glucose Monitor is calibrated to provide plasma equivalent results to laboratory methods. Nova Max One Glucose Test Strips are for testing outside the body (invitro diagnostic use only). The Monitor should only be used by a single user in the home and should not be shared by users. It is not intended for the diagnosis of or screening for diabetes, and it is not. intended for use on newborns.

Nova Max Control Solutions are intended for use with the Nova Max Blood Glucose Monitoring Systems as a quality control check to verify the accuracy of blood glucose test results. There are three levels of controls, (Levels 1,2,3).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K112638: Nova Max One Blood Glucose Monitor, Nova Max One Blood Glucose Test Strips.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K112638

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026